Clinical Trial Update: A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A dose-ranging Phase 1/2 trial evaluated delayed-release beclomethasone to prevent acute enteritis in patients with rectal cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enteritis
• Rectal Cancer

Drugs mentioned

• Delayed-release Beclomethasone (beclomethasone)

Snippet

Sponsor: Soligenix | Conditions: Enteritis | Phase 1, Phase 2 | Status: COMPLETED